Matches in SemOpenAlex for { <https://semopenalex.org/work/W17331313> ?p ?o ?g. }
- W17331313 abstract "Epidermal growth factor (EGF) is a 53-amino-acid growth factor (6.2 kDa) secreted by ectodermic cells, monocytes, kidneys, and duodenal glands (1). EGF stimulates growth of epidermal and epithelial cells. EGF and at least seven other growth factors and their transmembrane receptor kinases play important roles in cell proliferation, survival, adhesion, migration, and differentiation. The EGF receptor (EGFR) family consists of four transmembrane receptors, including EGFR (HER1/erbB-1), HER2 (erbB-2/neu), HER3 (erbB-3), and HER4 (erbB-4) (2). HER1, HER3, and HER4 comprise three major functional domains: an extracellular ligand-binding domain, a hydrophobic transmembrane domain, and a cytoplasmic tyrosine kinase domain. No ligand has been clearly identified for HER2. However, HER2 can be activated as a result of ligand binding to other HER receptors with the formation of receptor homodimers and/or heterodimers (3). HER1 as well as HER2 are overexpressed on many solid tumor cells such as breast, non-small-cell lung, head and neck, and colon cancer (4-6). The high levels of HER1 and HER2 expression on cancer cells are associated with a poor prognosis (7-10).Optical fluorescence imaging is increasingly used to monitor biological functions of specific targets in small animals (11-13). However, the intrinsic fluorescence of biomolecules poses a problem when fluorophores that absorb visible light (350–600 nm) are used. Near-infrared (NIR) fluorescence (650–1,000 nm) detection avoids the background fluorescence interference of natural biomolecules, providing a high contrast between target and background tissues. NIR fluorophores have a wider dynamic range and minimal background as a result of reduced scattering compared with visible fluorescence detection. NIR fluorophores also have high sensitivity, resulting from low fluorescence background, and high extinction coefficients, which provide high quantum yields. The NIR region is also compatible with solid-state optical components, such as diode lasers and silicon detectors. NIR fluorescence imaging is a noninvasive alternative to radionuclide imaging in small animals (14, 15).Fluorescent semiconductor quantum dots (QDs) are nanocrystals made of CdSe/CdTe-ZnS with radii of 1–10 nm (16, 17). They can be tuned to emit in a range of wavelengths by changing their sizes and composition, thus providing broad excitation profiles and high absorption coefficients. They have narrow and symmetric emission spectra with long, excited-state lifetimes, 20–50 ns, as compared with excited-state lifetimes of 1–10 ns for fluorescent dyes. They possess good quantum yields of 40%–90% and high extinction coefficients. They are more photo-stable than conventional organic dyes. They can be coated and capped with hydrophilic materials for additional conjugation with biomolecules, such as peptides, antibodies, nucleic acids, and small organic compounds, which were tested in vitro and in vivo (17-21). Although many cells have been labeled with QDs in vitro with little cytotoxicity, there are limited studies of long-term toxicity of QDs in small animals (22-30). However, little is known about the toxicity, and the mechanisms of clearance and metabolism of QDs in humans.Trastuzumab is a humanized IgG1 monoclonal antibody (Ab) against the extracellular domain of recombinant HER2, with an affinity constant (Kd) of 0.1 nM (31). 111In-Trastuzumab, Cy5.5-trastuzumab, and 68Ga-trastuzumab-F(ab')2 have been developed for imaging of human breast cancer (32-35). Trastuzumab has also been successfully coupled with quantum dots for optical imaging of HER2 in tumors in mice (36). Yang et al. (37) conjugated EGFR monoclonal Ab to QDs with a maximum emission wavelength of 800 nm to produce QD800-EGFR Ab nanoparticles for use with in vivo imaging of U14 head and neck squamous cell carcinoma (HNSCC) in nude mice." @default.
- W17331313 created "2016-06-24" @default.
- W17331313 creator A5005382198 @default.
- W17331313 date "2013-04-04" @default.
- W17331313 modified "2023-10-02" @default.
- W17331313 title "QD800-Anti-epidermal growth factor receptor monoclonal antibody nanoparticles" @default.
- W17331313 cites W1534575982 @default.
- W17331313 cites W1553198783 @default.
- W17331313 cites W1561712812 @default.
- W17331313 cites W1596261235 @default.
- W17331313 cites W1982322665 @default.
- W17331313 cites W1995251260 @default.
- W17331313 cites W1997005228 @default.
- W17331313 cites W2006174096 @default.
- W17331313 cites W2019026961 @default.
- W17331313 cites W2027175712 @default.
- W17331313 cites W2028534390 @default.
- W17331313 cites W2036752075 @default.
- W17331313 cites W2048053977 @default.
- W17331313 cites W2050289957 @default.
- W17331313 cites W2053961812 @default.
- W17331313 cites W2071987764 @default.
- W17331313 cites W2079906828 @default.
- W17331313 cites W2082717401 @default.
- W17331313 cites W2084380099 @default.
- W17331313 cites W2087052372 @default.
- W17331313 cites W2093902532 @default.
- W17331313 cites W2106955414 @default.
- W17331313 cites W2111812837 @default.
- W17331313 cites W2112101570 @default.
- W17331313 cites W2121831273 @default.
- W17331313 cites W2133638944 @default.
- W17331313 cites W2133782337 @default.
- W17331313 cites W2144175668 @default.
- W17331313 cites W2144857487 @default.
- W17331313 cites W2148924929 @default.
- W17331313 cites W2149447281 @default.
- W17331313 cites W2154321074 @default.
- W17331313 cites W2160499123 @default.
- W17331313 cites W2164624417 @default.
- W17331313 cites W2169782526 @default.
- W17331313 cites W2318354309 @default.
- W17331313 cites W51995314 @default.
- W17331313 hasPublicationYear "2013" @default.
- W17331313 type Work @default.
- W17331313 sameAs 17331313 @default.
- W17331313 citedByCount "0" @default.
- W17331313 crossrefType "journal-article" @default.
- W17331313 hasAuthorship W17331313A5005382198 @default.
- W17331313 hasConcept C101544691 @default.
- W17331313 hasConcept C153911025 @default.
- W17331313 hasConcept C170493617 @default.
- W17331313 hasConcept C185592680 @default.
- W17331313 hasConcept C197462201 @default.
- W17331313 hasConcept C24530287 @default.
- W17331313 hasConcept C2776362946 @default.
- W17331313 hasConcept C2779251935 @default.
- W17331313 hasConcept C2779438470 @default.
- W17331313 hasConcept C42362537 @default.
- W17331313 hasConcept C502942594 @default.
- W17331313 hasConcept C55493867 @default.
- W17331313 hasConcept C86803240 @default.
- W17331313 hasConcept C95444343 @default.
- W17331313 hasConceptScore W17331313C101544691 @default.
- W17331313 hasConceptScore W17331313C153911025 @default.
- W17331313 hasConceptScore W17331313C170493617 @default.
- W17331313 hasConceptScore W17331313C185592680 @default.
- W17331313 hasConceptScore W17331313C197462201 @default.
- W17331313 hasConceptScore W17331313C24530287 @default.
- W17331313 hasConceptScore W17331313C2776362946 @default.
- W17331313 hasConceptScore W17331313C2779251935 @default.
- W17331313 hasConceptScore W17331313C2779438470 @default.
- W17331313 hasConceptScore W17331313C42362537 @default.
- W17331313 hasConceptScore W17331313C502942594 @default.
- W17331313 hasConceptScore W17331313C55493867 @default.
- W17331313 hasConceptScore W17331313C86803240 @default.
- W17331313 hasConceptScore W17331313C95444343 @default.
- W17331313 hasLocation W173313131 @default.
- W17331313 hasOpenAccess W17331313 @default.
- W17331313 hasPrimaryLocation W173313131 @default.
- W17331313 hasRelatedWork W145055112 @default.
- W17331313 hasRelatedWork W196185429 @default.
- W17331313 hasRelatedWork W1965754302 @default.
- W17331313 hasRelatedWork W1988513472 @default.
- W17331313 hasRelatedWork W2006678930 @default.
- W17331313 hasRelatedWork W2027342147 @default.
- W17331313 hasRelatedWork W2027922061 @default.
- W17331313 hasRelatedWork W208639865 @default.
- W17331313 hasRelatedWork W2131443651 @default.
- W17331313 hasRelatedWork W2401720165 @default.
- W17331313 hasRelatedWork W2414379703 @default.
- W17331313 hasRelatedWork W2440228665 @default.
- W17331313 hasRelatedWork W2468622468 @default.
- W17331313 hasRelatedWork W2765906894 @default.
- W17331313 hasRelatedWork W2776312646 @default.
- W17331313 hasRelatedWork W2917226906 @default.
- W17331313 hasRelatedWork W52796893 @default.
- W17331313 hasRelatedWork W64565635 @default.
- W17331313 hasRelatedWork W65791924 @default.
- W17331313 hasRelatedWork W2186971118 @default.